SpineguardXPAR:ALSGD -2.79% OCF Margin % is -23.82% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Spineguard ranks worse than 76.69% on this metric.
The historical rank and industry rank for Spineguard's OCF Margin % or its related term are showing as below:
XPAR:ALSGD'
s OCF Margin % Range Over the Past 10 Years
Min: -84.6 Med: -26.98 Max: 3.28
Current: -27.71
During the past 13 years, the highest OCF Margin % of Spineguard was 3.28%. The lowest was -84.60%. And the median was -26.98%.
XPAR:ALSGD's OCF Margin % is ranked worse than 76.69% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs XPAR:ALSGD: -27.71
Spineguard OCF Margin % Related Terms
Spineguard OCF Margin % Historical Data
* Premium members only.
The historical data trend for Spineguard's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALSGD vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Spineguard's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spineguard OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spineguard's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Spineguard's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spineguard (XPAR:ALSGD) has a OCF Margin % of -23.82% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Spineguard and its competitors. According to the industry distribution chart, Spineguard ranks #625 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 76.7%.
Is Spineguard's OCF Margin % too high?
Spineguard's current OCF Margin % is -23.82%. Based on the distribution chart, Spineguard ranks #625 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Spineguard's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spineguard ranks #625 out of 815 companies for OCF Margin %. This places Spineguard in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Spineguard and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spineguard's current OCF Margin % is -23.82%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spineguard stock overvalued right now?
Based on GuruFocus' analysis, Spineguard (XPAR:ALSGD) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.10, compared to a current price of €0.09 — trading 13% below its estimated fair value. The current OCF Margin % is -23.82%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Spineguard (XPAR:ALSGD), the current OCF Margin % is -23.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALSGD has been successfully added to your 